JP2004519453A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004519453A5 JP2004519453A5 JP2002554134A JP2002554134A JP2004519453A5 JP 2004519453 A5 JP2004519453 A5 JP 2004519453A5 JP 2002554134 A JP2002554134 A JP 2002554134A JP 2002554134 A JP2002554134 A JP 2002554134A JP 2004519453 A5 JP2004519453 A5 JP 2004519453A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- administered
- lipopolysaccharide
- antigens
- immunogenic nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 239000002158 endotoxin Substances 0.000 claims 5
- 230000002163 immunogen Effects 0.000 claims 5
- 229920006008 lipopolysaccharide Polymers 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 239000013543 active substance Substances 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims 1
- 229930010555 Inosine Natural products 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108010039918 Polylysine Proteins 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 244000052616 bacterial pathogen Species 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 229960003786 inosine Drugs 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 claims 1
- 108010011110 polyarginine Proteins 0.000 claims 1
- 229920000656 polylysine Polymers 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 244000052613 viral pathogen Species 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2001/000087 WO2001054720A1 (en) | 2000-01-28 | 2001-01-05 | Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| AT6702001 | 2001-04-25 | ||
| PCT/EP2002/000071 WO2002053185A2 (en) | 2001-01-05 | 2002-01-07 | Anti-inflammatory use of polycationic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004519453A JP2004519453A (ja) | 2004-07-02 |
| JP2004519453A5 true JP2004519453A5 (https=) | 2005-12-22 |
Family
ID=25608381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002554134A Pending JP2004519453A (ja) | 2001-01-05 | 2002-01-07 | ポリカチオン性化合物の用途 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1347776A2 (https=) |
| JP (1) | JP2004519453A (https=) |
| WO (1) | WO2002053185A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2484941A1 (en) | 2002-07-24 | 2004-02-05 | Intercell Ag | Antigens encoded by alternative reading frame from pathogenic viruses |
| EP2402026A3 (en) | 2002-09-13 | 2012-04-18 | Intercell AG | Method for isolating hepatitis C virus peptides |
| CN100355453C (zh) * | 2003-03-24 | 2007-12-19 | 英特塞尔股份公司 | 改进的疫苗 |
| ATE485056T1 (de) * | 2003-03-24 | 2010-11-15 | Intercell Ag | Verbesserte impfstoffe |
| TW200803872A (en) | 2005-07-29 | 2008-01-16 | Suntory Ltd | Compositions comprising fucoidan or a fucoidan hydrolysate and an immuno-stimulating material |
| IN2012DN02345A (https=) | 2009-09-16 | 2015-08-21 | Univ Duke | |
| US8765148B2 (en) | 2010-02-19 | 2014-07-01 | Valneva Austria Gmbh | 1C31 nanoparticles |
| WO2017079537A1 (en) | 2015-11-04 | 2017-05-11 | Duke University | Polycationic polymers for use in treating and detecting cancer |
| US12447464B2 (en) | 2016-12-22 | 2025-10-21 | Duke University | Polycationic microfibers and methods of using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1290141A (https=) * | 1968-05-31 | 1972-09-20 | ||
| JPH09176038A (ja) * | 1995-09-18 | 1997-07-08 | Hisamitsu Pharmaceut Co Inc | 抗炎症性アンチセンス薬物 |
| RS50101B (sr) * | 1996-02-24 | 2009-01-22 | Boehringer Ingelheim International Gmbh., | Farmaceutski preparati za imunomodulaciju |
| ATE259654T1 (de) * | 1998-06-26 | 2004-03-15 | Nutricia Nv | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen |
| JP2000256196A (ja) * | 1999-03-05 | 2000-09-19 | Pias Arise Kk | 抗炎症，抗アレルギー剤 |
| DE60014076T2 (de) * | 1999-04-19 | 2005-10-13 | Glaxosmithkline Biologicals S.A. | Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid |
| JP2001199903A (ja) * | 1999-11-09 | 2001-07-24 | Eizo Mori | 核酸含有複合体 |
| AT410173B (de) * | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| AU2001281812B2 (en) * | 2000-06-08 | 2005-04-07 | Valneva Austria Gmbh | Immunostimulatory oligodeoxynucleotides |
-
2002
- 2002-01-07 JP JP2002554134A patent/JP2004519453A/ja active Pending
- 2002-01-07 EP EP02702238A patent/EP1347776A2/en not_active Withdrawn
- 2002-01-07 WO PCT/EP2002/000071 patent/WO2002053185A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1218031B1 (en) | Pharmaceutical composition comprising an antigen | |
| RU2328305C2 (ru) | Вакцинная композиция | |
| JP2003526662A5 (https=) | ||
| JP2010500399A5 (https=) | ||
| ATE392904T1 (de) | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid | |
| JP2008222721A6 (ja) | ワクチン組成物 | |
| RU2011121043A (ru) | ВАКЦИНА ПРОТИВ ПЕПТИДА CH3 IgE | |
| JP2007504237A5 (https=) | ||
| JP2001523729A5 (https=) | ||
| JP2003507341A5 (https=) | ||
| JP2005237328A5 (https=) | ||
| JP2004519453A5 (https=) | ||
| CN1030019A (zh) | 疫苗及其制备方法 | |
| RU2017129340A (ru) | Композиции nеisseria мeningitidis и способы их получения | |
| JP2003528112A (ja) | 強酸との生理学的に許容しうる付加塩の形態の、ｎ末端にグルタミン酸またはグルタミンを含む薬剤として有用な分子 | |
| KR101751376B1 (ko) | 점막 백신 | |
| CA2302833A1 (en) | Peptides derived from the attachment (g) protein of respiratory syncytial virus | |
| JP2006521321A (ja) | 免疫応答を促進するためのミョウバンおよびＴｈ１免疫応答誘起アジュバントの使用 | |
| Zhang et al. | Silk fibroin-coated nano-MOFs enhance the thermal stability and immunogenicity of HBsAg | |
| JP2005512518A5 (https=) | ||
| KR920004422A (ko) | Hiv의 주요 중화 결정인자 | |
| CN113939313A (zh) | 以肽核酸为基础的佐剂 | |
| CN113527417B (zh) | 一种含氟基团的自组装多肽纳米佐剂及其制备方法与应用 | |
| RU2007106900A (ru) | Иммуногенные комплексы, способ их приготовления и их применение в фармацевтических композициях | |
| EP2370100B1 (en) | Peptide adjuvants |